P53 Expression as a Prognostic Marker in Inflammatory Breast Cancer

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-04-0202
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Expression Status of Cyclase‑associated Protein 2 as a Prognostic Marker for Human Breast Cancer

Oncology Reports
MedicineCancer ResearchOncology
2016English

Immunofluorometrically Determined P53 Accumulation as a Prognostic Indicator in Italian Breast Cancer Patients

International Journal of Cancer
Cancer ResearchOncology
1998English

RIPK3 Expression as a Potential Predictive and Prognostic Marker in Metastatic Colon Cancer

Clinical and Investigative Medicine
Medicine
2019English

PD-L1 Expression of the Residual Tumor Serves as a Prognostic Marker in Local Advanced Breast Cancer After Neoadjuvant Chemotherapy

International Journal of Cancer
Cancer ResearchOncology
2017English

SETD3 Acts as a Prognostic Marker in Breast Cancer Patients and Modulates the Viability and Invasion of Breast Cancer Cells

Scientific Reports
Multidisciplinary
2020English

Circulating Cell-Free DNA and Its Integrity as a Prognostic Marker for Breast Cancer

SpringerPlus
Multidisciplinary
2015English

Sialyl Tn as a Prognostic Marker in Epithelial Ovarian Cancer

British Journal of Cancer
Cancer ResearchOncology
1992English

Expression of Stemness Genes in Primary Breast Cancer Tissues: The Role of SOX2 as a Prognostic Marker for Detection of Early Recurrence

Oncotarget
Oncology
2014English

Expression of RNA-binding Protein Musashi-2, as a Negative Prognostic Marker in Metastatic Colorectal Cancer.

Современные проблемы науки и образования (Modern Problems of Science and Education)
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy